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Abstract: Background: Xenograft rejection of pigs organs with an engi-
neered mutation in the GGTA-1 gene (GTKO) remains a predomi-
nantly antibody mediated process which is directed to a variety of non-
Gal protein and carbohydrate antigens. We previously used an expres-
sion library screening strategy to identify six porcine endothelial cell
cDNAs which encode pig antigens that bind to IgG induced after pig-
to-primate cardiac xenotransplantation. One of these gene products was
a glycosyltransferase with homology to the bovine b1,4 N-acetylgalac-
tosaminyltransferase (B4GALNT2). We now characterize the porcine
B4GALNT2 gene sequence, genomic organization, expression, and
functional signiﬁcance.
Methods: The porcine B4GALNT2 cDNA was recovered from the ori-
ginal library isolate, subcloned, sequenced, and used to identify a bacte-
rial artiﬁcial chromosome (BAC) containing the entire B4GALNT2
locus from the Children’s Hospital Oakland Research Institute BAC-
PAC Resource Centre (#AC173453). PCR primers were designed to
map the intron/exon genomic organization in the BAC clone. A stable
human embryonic kidney (HEK) cell line expressing porcine B4GAL-
NT2 (HEK-B4T) was produced. Expression of porcine B4GALNT2 in
HEK-B4T cells was characterized by immune staining and siRNA
transfection. The eﬀects of B4GALNT2 expression in HEK-B4T cells
was measured by ﬂow cytometry and complement mediated lysis. Anti-
body binding to HEK and HEK-B4T cells was used to detect an
induced antibody response to the B4GALNT2 produced glycan and the
results were compared to GTKO PAEC speciﬁc non-Gal antibody
induction. Expression of porcine B4GALNT2 in pig cells and tissues
was measured by qualitative and quantitative real time reverse trans-
criptase PCR and by Dolichos biﬂorus agglutinin (DBA) tissue staining.
Results: The porcine B4GALNT2 gene shares a conserved genomic
organization and encodes an open reading frame with 76 and 70%
amino acid identity to the human and murine B4GALNT2 genes,
respectively. The B4GALNT2 gene is expressed in porcine endothelial
cells and shows a broadly distributed expression pattern. Expression of
porcine B4GALNT2 in human HEK cells (HEK-B4T) results in
increased binding of antibody to the B4GALNT2 enzyme, and
increased reactivity with anti-Sd
a and DBA. HEK-B4T cells show
increased sensitivity to complement mediated lysis when challenged with
serum from primates after pig to primate cardiac xenotransplantation.
In GTKO and GTKO:CD55 cardiac xenotransplantation recipients
there is a signiﬁcant correlation between the induction of a non-Gal
antibody, measured using GTKO PAECs, and the induction of antibod-
ies which preferentially bind to HEK-B4T cells.
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XENOTRANSPLANTATIONConclusion: The functional isolation of the porcine B4GALNT2 gene
from a PAEC expression library, the pattern of B4GALNT2 gene
expression and its sensitization of HEK-B4T cells to antibody binding
and complement mediated lysis indicates that the enzymatic activity of
porcine B4GALNT2 produces a new immunogenic non-Gal glycan
which contributes in part to the non-Gal immune response detected
after pig-to-baboon cardiac xenotransplantation.
Introduction
Carbohydrate modiﬁcations on glycoproteins and
glycolipids are involved in a wide array of biologi-
cal processes including protein stability, develop-
ment, and cell growth. Variations in carbohydrate
modiﬁcation between individuals and between spe-
cies deﬁne a form of immune self-recognition. Dif-
ferences in expression of ABH blood group
antigens between individuals has long been recog-
nized as a prohibitive boundary across which
blood transfusion and organ transplantation is
generally not performed. Individuals which do not
express a particular ABH antigen are stimulated
by intestinal microﬂora to produce antibody to
that glycan. This preformed antibody can induce a
hemolytic reaction or promote hyperacute or accel-
erated allograft rejection of ABH incompatible
grafts. The same process occurs across species.
Humans and Old World primates do not produce
oligosaccharides with terminal galactose a 1,3,
galactose (aGal), whereas all other mammals syn-
thesize terminal aGal glycans [1]. As a conse-
quence, humans make high levels of anti-Gal
antibody. Anti-Gal antibody is a major immune
barrier to xenotransplantation [2]. This antibody
has also been implicated in other clinical patholo-
gies, notably the accelerated calciﬁcation of glutar-
aldehyde-ﬁxed porcine bioprosthetic material and
degeneration of bioprosthetic replacement heart
valves [3,4].
Targeted genetic modiﬁcation has been used to
mutate the a-galactosyltransferase (GGTA-1) gene
of the pig (GTKO) [5–7]. This mutation eliminates
the enzyme function and, when homozygous,
blocks the synthesis of terminal aGal moieties on
glycoproteins [8–11]. Porcine GTKO tissue does
not bind anti-Gal antibody and transplantation of
GTKO cells, tissue and organs does not induce a
speciﬁc anti-Gal antibody response. Elimination of
this antigen has not eliminated GTKO xenograft
rejection which remains a predominantly anti-
body-mediated process now directed to non-Gal
antigens [12,13]. We have used proteomic analysis
of porcine aortic endothelial cell (PAEC) mem-
branes and expression library screening of PAEC
cDNA libraries to identify immunogenic non-Gal
target antigens that may contribute to xenograft
rejection [14,15]. Using sera, obtained after pig-to-
baboon cardiac xenotransplantation, these studies
identiﬁed 43 potential non-Gal target antigens
including six cDNAs, isolated from PAEC expres-
sion libraries. When expressed on human embry-
onic kidney 293 cells (HEK) these cDNAs each
produce a porcine antigen that binds to baboon
non-Gal IgG. A BLAST search identiﬁed one of
these recovered cDNAs as a porcine glycosyltrans-
ferase with homology to a predicted Bos Taurus
b1,4 N-acetylgalactosaminyltransferase (B4GAL-
NT2) sequence [14]. In humans and mice the
B4GALNT2 gene catalyzes the terminal addition
of N-acetylgalactosamine to a sialic acid modiﬁed
lactosamine to produce GalNAc b1-4[Neu5Ac a2-
3]Gal b1-4GlcNAc b1-3Gal, the Sd
a (Sid blood
group, also known as CAD or CT) blood group
antigen [16,17]. In this study, we further character-
ize the porcine B4GALNT2 coding sequence,
genomic organization, expression, and functional
signiﬁcance.
Materials and methods
Cells, culture conditions, and transfection methods
Porcine aortic endothelial cells (PAECs) were iso-
lated from GTKO A- and O-type blood group pig
aortas as previously described [18] and cultured in
EGM media (Lonza Inc., Allendale, NJ, USA).
Porcine peripheral blood mononuclear cells
(PBMCs) were isolated from GTKO pig blood by
density gradient centrifugation using Ficoll–Hyp-
aque. Human embryonic kidney 293 cells (HEK)
and HEK cells expressing the porcine B4GALNT2
cDNA were grown in DMEM media with 10%
FBS at 37 °C in a 5% CO2 incubator. The full
length pig B4GALNT2 open reading frame was
ampliﬁed from the original library isolated clone
using a primers set containing a Kozak consensus
sequence and in-frame translation stop signals,
respectively (Forward: 50- ACCATGACTTCGTA
CAGCCCTAG-30, Reverse: 50- CAGATACCTTA
GGTGGCACATTGGAG-30). The PCR product
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expression vector (Life Technologies, Paisley, UK)
and transfected into HEK cells using Lipofecta-
mine-2000 (Life Technologies). A stable G418
resistant HEK clone expressing the porcine
B4GALNT2 genes (HEK-B4T) was established
and used for further real-time RT-PCR, immuno-
histochemical staining, complement dependent
cytotoxicity, and ﬂow cytometry analysis.
siRNA isolation and transfection
B4GALNT2 speciﬁc siRNA and control siRNA
for glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) were generated from the coding region
of each gene using a BLOCK-iT Dicer RNAi Kit
(Life Technologies) according to the manufac-
turer’s instruction. RNAi primers for B4GALNT2
were: Forward: 50-ATGACTTCGTACAGCCCT
AG-30 and Reverse: 50-CAGATACCTTAGGTG
GCACATTGGAG-30. RNAi primers for GAPDH
were Forward: 50-AGGTGAAGGTCGGAGTCA
AC-30 and Reverse: 50-AGTGGTCGTTGAGG
GCAATG-30. The diced siRNA was puriﬁed
through a RNA Spin Cartridge (Life Technolo-
gies). B4GALNT2 and GAPDH diced siRNAs
were transfected into HEK-B4T cells using
Lipofectamine-2000 (Life Technologies). After
48 h, total RNA was extracted from cells using
RNeasy Plus Mini kit (Qiagen Inc., Valencia, CA.
USA). B4GALNT2 expression was monitored by
real-time RT-PCR and immunohistochemical
staining.
Real-time and qualitative RT-PCR analysis of B4GALNT2
expression
Total RNA was extracted from cultured cells using
RNeasy Plus Mini kit (Qiagen Inc.). Porcine tissue
RNA was extracted using 1 g of frozen pig tissue
homogenized in 10 ml cold STAT-60 RNA (Tel-Test
Inc., Friendswood, TX, USA) and processed as rec-
ommended. For both qualitative and quantitative
reverse transcriptase PCR (RT-PCR) RNA quality
was assessed using an Agilent 2100 Bioanalyzer
(Agilent Technologies Inc., Santa Clara, CA, USA).
To survey the expression of porcine B4GALNT2
a gene speciﬁc one-step reverse transcriptase PCR
(RT-PCR) assay using 0.5 lg of total tissue RNA
and primers for pig B4GALNT2 (Forward: TAC-
AGCCCTAGATGTCTGTC in exon 1, Reverse:
CTCTCCTCTGAAAGTGTTCGAG in exon 3)
was used to amplify a 334 bp product. Primers for
beta-actin (Forward: CAAGATCATCGCGCCTC
CA exon 6, Reverse: ACTCCTGCTTGCTGAT
CCACATCT, exon 6) produce a 108 bp product
which was used as a loading control. The authen-
ticity of each ampliﬁed PCR product was con-
ﬁrmed by sequencing. Gene speciﬁc ampliﬁcation
was performed in a MyCycler Thermal Cycler
(Bio-Rad, Hercules, CA, USA) using one-step
RT-PCR reaction (USB-Aﬀymetrix, Santa Clara,
CA, USA) with reverse transcription performed
at 50 °C for 30 min. Ampliﬁcation conditions
consisted of 95 °C for 10 min, and 30 cycles of
94 °C for 30 s, 60 °C for 30 s and 72 °C for 30 s.
Ampliﬁcation products were run in a 1.5% agarose
gel.
For quantitative real-time analysis (Figs 3C and
4B) QuantiTect SYBR Green one-step RT-PCR
was used (Qiagen Inc.) according to the manufac-
ture’s instruction. The cycling conditions were as
follows: 50 °C for 30 min for reverse transcriptase,
95 °C for 15 min, and 40 cycles of 94 °C for 15 s,
60 °C for 30 s, and 72 °C for 30 s. The B4GAL-
NT2 primers for quantitative real time PCR (Fig.
3C) were: rt-Forward: 50-GCGACTCCAAA-
GAATTGGCTTC-30 (exon 10) and rt-Reverse 50-
TGGTGACCTATGATCACGTGTG-30(exon 11)
which produces a 120 bp RT-PCR product. A nor-
malized dCT was calculated using b-actin expres-
sion and the relative change in B4GALNT2
expression, ddCT, was calculated based on
B4GALNT2 expression in the absence of siRNA
[19]. Pig and PAEC AO blood group determina-
tion was performed as described [20].
Cell staining and ﬂow cytometry
Fluorescein isothiocyanate conjugated Dolichos
biﬂorus agglutinin (FITC-DBA; Vector Labs, Bur-
lingame, CA, USA) and an anti-Sd
a antibody
KM694 (kindly provided by Kyowa Hakko Kirin
Co. Ltd., Tokyo, Japan) were used to detect the
glycan products of porcine B4GALNT2 expression
in cultured human cells. Cells (2.5 9 10
5) in FACS
buﬀer (phosphate buﬀered saline (PBS) with 1%
bovine serum albumin) were stained with 1 to
5 lg/ml KM694 or 10 lg/ml of FITC-DBA for
45 min at 4 °C. Cells stained with KM694 were
washed in FACS buﬀer and subsequently stained
with a FITC conjugated goat anti-mouse IgM
(2 lg/ml Southern Biotech, Birmingham, AL,
USA). All cells were analyzed using a FACSCali-
bur (BD Biosciences, San Jose, CA, USA) cytome-
ter and CellQuest software.
Immunohistochemical staining of HEK and
HEK-B4T cells with rabbit anti-human B4GAL-
NT2 (Sigma-Aldrich, Saint Louis., MO, USA) was
used to assess B4GALNT2 protein expression after
siRNA transfection. Cells were ﬁxed in cold meth-
anol, washed with PBS containing 0.1% Triton
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Cells were incubated with rabbit anti-human
B4GALNT2 in FACS buﬀer (1 : 75 dilution) for
2 h and washed with PBS. Anti-B4GALNT2 bind-
ing was detected with an anti-rabbit diaminobenzi-
dine kit (ZymedLife Technologies, Paisley, UK) as
recommended by the manufacturer.
Induced antibody directed to the B4GALNT2
produced porcine glycan after pig-to-baboon het-
erotopic GTKO or GTKO:CD55 cardiac xeno-
transplantation was measured by comparing
diﬀerential antibody binding to HEK and HEK-
B4T cells. Cells (2.5 9 10
5) were stained with pre-
transplant, and post-explant serial serum dilutions
(1 : 5 to 1 : 40) at 4 °C for 45 min in FACS buﬀer.
After washing, bound antibody was detected using
a phycoerythrin conjugated goat anti-human IgM
or IgG secondary. Induction of antibody speciﬁc
for the B4GALNT2 produced glycans was esti-
mated as the ratio of induced antibody binding to
HEK-B4T cells compared to HEK cells (anti-
B4GALNT2 glycan = MFI post explant (HEK-
B4T)/pretransplant (HEK-B4T): MFI post-explant
(HEK)/pretransplant (HEK). Post-explant induc-
tion of non-Gal antibody was measured using
GTKO PAECs as previously described using
serum samples from earlier GTKO or GTKO:
CD55 heterotopic cardiac transplants [11] or trans-
plant recipients subject to similar immune suppres-
sion. The induced antibody binding data were used
to calculate a Spearman rank correlation coeﬃ-
cient for IgM and IgG speciﬁc reactivity to
HEK-B4T cells and GTKO PAECs. A two tailed
non-directed P-value < 0.05 was considered signiﬁ-
cant. In Table 2, the induced HEK-B4T antibody
response is represented in a semi-quantitative scale
with ratios <2 scored as negative, 2.0 to 2.5 + , 2.5
to 5.0 ++, 5.0 to 10.0 +++, and greater than
10 ++++.
Complement-mediated lysis
Human embryonic kidney and HEK-B4T cells
(2 9 10
5) were incubated with a dilution of heat
inactivated baboon serum at 4 °C for 45 min,
washed with PBS, and resuspended in 20% fresh
rabbit complement (Sigma-Aldrich) at 37 °C for
1 h. Cell were stained with propidium iodide
(3 lg/ml) placed on ice and analyzed on a FACS
Calibur ﬂow cytometer. Samples were analyzed in
triplicate and the average proportion of propidium
iodide stained cells is reported. Baboon serum
came from previously described pig to primate car-
diac xenograft recipients [14,21]. Serum heat inacti-
vation was performed at 56 °C for 30 min using a
temperature controlled water bath.
DBA lectin staining of pig tissues
Fresh pig tissues were embedded and snap frozen
in optimal cutting temperature material (OCT.
Miles Laboratories, Elkhart, IN, USA). Sections
(8 lm) were cut, air dried, and acetone ﬁxed prior
to staining. Sections were cleared of OCT by wash-
ing in distilled water and PBS, blocked with FACS
buﬀer and stained with FITC-DBA (4 lg/ml) in
FACS buﬀer at 4 °C overnight, washed with PBS
and mounted in Vectashield mounting medium
with DAPI (Vector Laboratories, Burlingame, CA,
USA). Stained sections were photographed using a
Leica DMI4000B ﬂuorescent microscope (Leica
Microsystems, Buﬀalo Grove, IL, USA).
Results
Sequence analysis and genomic organization
Expression screening of a porcine aortic endothe-
lial cell (PAEC) library using IgG induced after
pig-to-baboon cardiac xenotransplantation iso-
lated a porcine cDNA with 54 base pairs of 50
untranslated sequence, a 1509 base pair open read-
ing frame and 459 bp of 30 untranslated sequence
including a putative polyadenylation sequence
(Fig. 1A, GenBank accession: KF501048). A
BLAST search identiﬁed this cDNA as a porcine
glycosyltransferase with homology to known or
predicted b1,4 N-acetylgalactosaminyltransferase
(B4GALNT2) products from several mammalian
species including the human and mouse B4GAL-
NT2 proteins. A comparison of these protein
sequences shows the porcine open reading frame to
have 76 and 70% amino acid identity to human
and murine B4GALNT2 proteins, respectively
(Fig. 1B). In contrast amino acid identity to the
related human and murine B4GALNT1 protein is
<50% (data not shown). Analysis of the porcine pro-
tein sequence with the NCBI Conserved Domain
Database [22] identiﬁed a putative GT-A type fold
(underlined). This region includes a conserved struc-
tural motif (SQVTTKYVLWVDDDF), present in
both human and murine B4GALNT2, which con-
tains an acidic divalent cation binding site (DXD)
commonly found in glycosyltransferases which use a
UDP-sugar as the donor substrate [23].
To map the genomic organization, the porcine
B4GALNT2 cDNA was used to identify a porcine
BAC clone obtained from the Children’s Hospital
Oakland Research Institute BACPAC Resource
Centre (#AC173453). Based on the intron/exon
structure of human and mouse B4GALNT2 and
the porcine genomic sequences derived from the
Sus scrofa working draft of AC173453.2, clone
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Byrne et al.Fig. 1. Sequence and homology comparison of porcine B4GALNT2. (A) Sequence of the porcine B4GALNT2 cDNA (GenBank:
KF501048). Numbering begins with the start codon. Uppercase letters are the protein coding sequences, lower case letter are untrans-
lated sequences. (B) Amino acid homology comparison between porcine, human and murine B4GALNT2 protein sequences. An
asterisk indicates a shared amino acid identity, a line indicates a conserved amino acid substitution and a space indicates a non-con-
served amino acid residue. The underlined region represents a conserved GT-A fold [22] and the boxed region highlights the con-
served divalent cation binding domain [23].
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(Table 1) to conﬁrm the intron exon structure of
the porcine B4GALNT2 gene (Fig. 2A). These
primers ampliﬁed exons 1 to 11, including variable
lengths of neighboring intron sequence, and ampli-
ﬁed introns 5 to 8 and 10. All PCR products were
sequenced and compared to the original B4GAL-
NT2 cDNA to identify intron-exon junction
sequences (Fig. 2B). The cDNA coding region is
composed of 11 exons spread across approximately
40 000 base pairs. Exon 1 contains translation ini-
tiation start site and 50 untranslated sequences. We
have not directly mapped the transcriptional start
site of the gene so there may be additional 50
untranslated sequence or an upstream exon(s) not
depicted in this ﬁgure. During the course of this
study, a sequence for porcine B4GALNT2 99%
identical to the clone we reported was added to the
database (NM_001244330).
Expression of porcine B4GALNT2 in human HEK cells
A stable G418 resistant HEK cell line expressing
the porcine B4GALNT2 cDNA (HEK-B4T) was
produced. This cell line bound higher levels of rab-
bit anti-human B4GALNT2 antibody (Fig. 3A)
compared with control HEK cells. The increased
antibody binding was speciﬁc for expression of
porcine B4GALNT2 mRNA as HEK-B4T cells
transfected with siRNA to porcine B4GALNT2
exhibit an 80% decrease in porcine B4GALNT2
mRNA expression and a proportionate reduction
in anti-human B4GALNT2 antibody binding
(Fig. 3B,C). No change in anti-B4GALNT2 stain-
ing or expression of B4GALNT2 mRNA was evi-
dent when cells were transfected with siRNA for
GAPDH.
The human and mouse B4GALNT2 gene pro-
duces GalNAc b1-4[Neu5Ac a2-3]Gal b1-4Glc-
NAc b1-3Gal, the Sd
a blood group glycan, by the
addition of a b1,4 N-acetyl galactosamine to a sia-
lic acid modiﬁed lactosamine acceptor. HEK cells,
but not HUVECs, bind a low level of anti-Sd
a
hybridoma KM694 (Fig. 3D). The HEK-B4T cell
line shows increased binding of KM694 consistent
with increased synthesis of the Sd
a antigen as a
result of expression of porcine B4GALNT2. The
Dolichos biﬂorus agglutinin (DBA) binds alpha
linked terminal GalNAc structures [24], but also
binds beta GalNAc residues as presented in the
Sd
a glycan. The DBA lectin has been used to iso-
late the Sd
a pentasaccharide from murine small
intestine [25], shows diﬀerential binding to humans
Sd
a+ and Sd
a  glycoproteins [26], and is com-
monly used to detect the Sd
a antigen on cells and
in tissue sections [17,27,28]. HEK-B4T cells bind
high levels of DBA and are strongly agglutinated
by this lectin (Fig. 3E). Expression of porcine
B4GALNT2 in HEK-B4T cells increases cell sensi-
tivity to complement mediated cytotoxicity
(Fig. 3F). HEK-B4T cells show a 20-fold enhance-
ment of antibody-dependent complement-medi-
ated lysis compared to HEK cells when challenged
with pig-to-baboon cardiac xenotransplantation
sensitized recipient serum.
Immunogenicity of B4GALNT2 produced antigens
Heterotopic GTKO or GTKO:CD55 cardiac xeno-
graft recipients show variable induction of IgG
and IgM binding to GTKO PAECs (Table 2).
Comparing pretransplant and post explant serum
(obtained from immune suppressed recipients 1 to
3 weeks after organ recovery) three recipients (sur-
vival 28, 27, and 22 days) showed a clear 2- to
8-fold increase in non-Gal antibody and four recip-
ients (survival 71, 31, 21, and 18 days) showed a
minimal non-Gal antibody response. We used dif-
ferential antibody binding to HEK-B4T and HEK
cells to determine if this induced non-Gal antibody
response included antibody reactivity speciﬁc
to the glycans expressed on the HEK-B4T cell
Table 1. Primers for mapping the porcine B4GALNT2 genomic
structure
No. ID Sequence
BP to
exon Site
1 Exon1-F AAGGCAGGACCTAGAAGGTG 90 ﬂank exon 1
2 Exon1-R AACGAGCAGGAACTCTCAAC 185 ﬂank exon 1
3 Exon2-F GCTGTGCAAAAGCTTGTCAGTTTGC 186 ﬂank exon 2
4 Exon2-R CACAGTAAAGCCACAGGAGGAG 41 ﬂank exon 2
5 Exon3-F CCCAATCTGTGATCTTTGAC 24 ﬂank exon 3
6 Exon3-R GGAATGAGTAGAGAGCTTCC 41 ﬂank exon 3
7 Exon4-F ATCTGGCATGGTCAGTGCATTG 145 ﬂank exon 4
8 Exon4-R CAGTGGTGGAAACAGTGAG 150 ﬂank exon 4
9 Exon5-F AACTCTTGGCATCCTCTC 51 ﬂank exon 5
10 Exon5-R TGAGACCAGCCACCATCTCA 73 ﬂank exon 5
11 Exon7-F AGTGACCCAGATACCGTG 29 ﬂank exon 6
12 Exon7-R CTAAGGATCCAGTGTTGTCAC 224 ﬂank exon 6
13 Exon8-F TCCACAAACACTCGAGACAG 84 ﬂank exon 7
14 Exon8-R TGGGTAGTACTCACGAACACTC n/a in exon 8
15 Exon9-F AGAGAGTCCCTCTCCTTCTTC 152 ﬂank exon 9
16 Exon9-R TCAGATGGCAATGGGGTAGAAC 22 ﬂank exon 9
17 Exon10-F ACAGGCTCCTTGGATATGGAG 36 ﬂank exon 10
18 Exon10-R TTGACAACACCACTGGTCACCAC n/a in exon 10
19 Intron5-F GTTTGAAGGACCTGATGCTC n/a in exon 5
20 Intron5-R TGTTCAGTGTCCCCAGAGAAG n/a in exon 6
21 Intron6-F ACACGAGCACAGAGTACCACC n/a in exon 6
22 Intron6-R AAACTTGGCCACTGAGGACTTG n/a in exon 7
23 Intron8-F GACAGCCACGTGGAGTATTAC n/a in exon 8
24 Intron8-R TGAGATATGGCCAGGTTTCTG n/a in exon 9
25 Intron10-F GCGACTCCAAAGAATTGGCTTC n/a in exon 10
26 Intron10-R TGGTGACCTATGATCACGTGTG n/a in exon 11
The table list the names, sequences, and location of primers used to conﬁrm the
genomic organization of the porcine B4GALNT2 gene. Primer numbers (No.) corre-
spond to values in Fig. 2A. Not applicable, n/a.
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IgM (r = 0.8929) and IgG (r = 0.8571) reactivity
to HEK-B4T cells was signiﬁcantly correlated with
the induced non-Gal antibody response to GTKO
PAECs (Table 2). Recipients with a clear induced
antibody response to GTKO PAECs also showed
increased antibody reactivity for HEK-B4T cells.
The antibody (IgG) reactivity to HEK-B4T cells in
sensitized baboon serum can be blocked by
immune absorption with GTKO PAECs (Fig. 4A)
but is unaﬀected by immune absorption using
human umbilical vein endothelial cells (HUVECs)
(Fig. 4B). This suggests that the induced xenoreac-
tive antibody response in baboons includes anti-
body directed to glycan antigens present on both
HEK-B4T and GTKO PAECs, but not present on
HUVECs which are negative for B4GALNT2
expression and the Sd
a antigen (Fig. 3D).
Expression of B4GALNT2 in porcine tissue
A panel of pig tissues was assessed for B4GALNT2
expression by qualitative RT-PCR. Expression
of B4GALNT2 RNA was evident in cultured
PAECs, peripheral blood mononuclear cells and at
variable levels in most GT
+ porcine tissues
(Fig. 5A). Expression of B4GALNT2 RNA was
not strongly aﬀected by the GGTA-1 Gal genotype
as heterozygous (GGTA-1+/ ) and GTKO pig tis-
sues exhibited a similar pattern of B4GALNT2
expression (data not shown). Quantitative real
time RT-PCR analysis of B4GALNT2 gene
expression in cultured GT
+ and GTKO PAECs of
the A- and O-type blood groups showed only mod-
erate variation in B4GALNT2 expression
(Fig. 5B). Expression of porcine B4GALNT2 in
HEK-B4T cells resulted in increased DBA and
KM694 antibody binding in HEK-B4T cells
(Fig. 3D,E), however, PAECs show only strong
DBA agglutination (Fig. 5C) and do not stain with
the anti-Sd
a antibody KM694 (Fig. 5D). DBA
staining of GTKO pig tissues (O-type blood group)
was observed in vascular endothelial cells of the
heart, in glomeruli and larger blood vessels in the
kidney and by the reticuloendothelial cells of the
liver (Fig. 5E–G).
Fig. 2. Schematic representation of the intron-exon organization (A) and splice junction sequences (B) of the porcine B4GALNT2
gene. (A) Shaded boxes represent exon coding sequences numbered E1–E11. Open boxes correspond to untranslated sequences pres-
ent in the cDNA. The size of each exon is indicated in base pairs above each box and the intron distances are indicated below
between each exon. The primer pairs (1–26, see Table 1) and ampliﬁed products used to analyze the genomic structure from a BAC
clone are illustrated below the genomic structure as solid bars for products covering exon/intron boundaries and open bars for prod-
ucts spanning entire introns. The primer numbering corresponds to the primers listed in Table 1. (B) The proximal splice donor and
distal splice acceptor nucleotide sequences (upper case) for each exon are shown. Adjacent intervening intron sequences (lower case)
are shown. Exon numbering corresponds to (A).
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The porcine B4GALNT2 cDNA was originally
isolated during a ﬂow cytometry based library
screen to identify human HEK cells expressing
porcine cDNAs which encoded surface membrane
antigens that bound to sensitized primate IgG after
GT
+ or GTKO pig cardiac xenotransplantation
[14]. The porcine cDNA and its encoded protein
show the highest homology to the B4GALNT2
gene with 76 and 70% amino acid identity with the
human and mouse gene, respectively (Fig. 1). We
show that the porcine gene also shares with human
and mouse a conserved intron/exon genomic orga-
nization (Fig. 2). Consistent with a conserved pro-
tein sequence a stable HEK cell line expressing the
porcine cDNA (HEK-B4T) binds increased levels
of rabbit anti-human B4GALNT2 antisera and,
using siRNA inhibition, we show this binding is
dependent on expression of the porcine cDNA
(Fig. 3B,C). Expression of the porcine cDNA in
HEK-B4T cells also results in increased binding of
anti-Sd
a antibody and DBA lectin. On this struc-
tural and functional data, we conclude that the iso-
lated porcine cDNA encodes the porcine
B4GALNT2 gene.
Porcine B4GALNT2 enzymatic activity has been
reported from swine large intestine mucosal cells
[29] and immunostaining of the Sd
a antigen has
been detected in porcine primordial germ cells [30].
To our knowledge, this is the ﬁrst molecular analy-
sis of porcine B4GALNT2 gene expression in pig
tissues. In the pig, we ﬁnd B4GALNT2 mRNA
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Fig. 3. Expression of B4GALNT2 protein and synthesis of the Sd
a antigen on HEK-B4T cells. (A) HEK-B4T cells show increased
anti-human B4GALNT2 staining compared to HEK cells (insert). (B) Staining is dependent on porcine B4GALNT2 mRNA expres-
sion as HEK-B4T cells transfected with porcine B4GALNT2 siRNA show decreased staining compared to cell transfected with con-
trol GAPDH siRNA (insert in B). (C) Quantitative real-time RT-PCR analysis of B4GALNT2 RNA in HEK-B4T cells after
transfection with control (siGAPDH) or porcine speciﬁc (siB4GALNT2) siRNA. Gene expression was normalized to pig beta-actin
(dCT) and expressed as a ratio to B4GALNT2 expression in HEK-B4T cells without siRNA transfection (ddCT). Error bars are
standard error of the mean. (D) Flow cytometry detection of anti-Sd
a antibody (KM694) binding to HEK (dotted line) and
HEK-B4T cells (black line ﬁlled). Background is secondary antibody only binding to HEK cells (ﬁlled no line). KM694 binding to
HUVECs (solid line no ﬁll) is negative. (E) FITC conjugated Dolichos biﬂorus agglutinin (DBA) staining of HEK-B4T cells lines
(black line) and control HEK cells (ﬁlled). (F) Complement-dependent cytotoxicity of HEK (open) and HEK-B4T (ﬁlled) cells
challenged with primate serum after pig-to-primate xenotransplantation.
Table 2. Differential immune response to HEK-B4T cells after cardiac
xenotransplantation
Donor
Survival
(days)
HEK-B4T
IgM
HEK-B4T
IgG
GTKO
PAEC IgM
GTKO
PAEC IgG
GTKO:CD55 71   + 0.5 0.6
GTKO:CD55 31   0.5 0.4
GTKO:CD55 28 +++ +++ 4.8 2.5
GTKO:CD55 27 +++ + 2.2 8.5
GTKO 22 +++ ++++ 1.9 7.3
GTKO 21   1.3 0.9
GTKO:CD55 18   0.4 0.4
Table shows the speciﬁc induced antibody response in pig-to-baboon heterotopic
cardiac xenograft recipients directed to the B4GALNT2 (HEK-B4T) glycan or to
GTKO PAECs. Antibody reactivity to HEK-B4T cells was estimated as described in
the Materials and Methods. There was a positive and signiﬁcant (P < 0.05) Spear-
man rank correlation coefﬁcient between the anti-PAEC and anti-HEK-B4T IgM
(r = 0.8929) and IgG (r = 0.8571) immune response.
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Byrne et al.expression in PAECs, peripheral blood mononu-
clear cells, and across a wide array of tissues
(Fig. 5A). This porcine B4GALNT2 gene expres-
sion pattern is in distinct contrast to humans and
most strains of mice where B4GALNT2 expression
and the Sd
a antigen, generally detected by lectin
staining, is largely restricted to gastrointestinal,
skin and renal tissues and is notably absent from
arteries, heart and skeletal muscle [23,27,31,32].
Vascular expression of B4GALNT2 is not unprec-
edented however as mice which carry the modiﬁer
of von Willebrand factor-1 (Mvwf1) mutation
exhibit a shift from gastrointestinal epithelial cell
expression to vascular endothelial cell expression
of B4GALNT2 [27].
The B4GALNT2 cDNA was originally isolated
by screening an expression library with post trans-
plant IgG from pig-to-baboon cardiac heterotopic
xenotransplantation recipients transplanted with-
out T-cell immune suppression [14,21]. In these
recipients, the non-Gal immune response was espe-
cially strong and ﬁve of ﬁve transplant recipients
showed an induced immune response with prefer-
ential binding to HEK-B4T cells [14]. In this study,
we extend our previous results and show in recipi-
ents subject to substantial immune suppression
that there is a correlation between an induced non-
Gal antibody response and the induction of anti-
body with preferential binding to HEK-B4T cells
(Table 2). We further show that expression of the
porcine B4GALNT2 gene in HEK-B4T cells pro-
duced a 20-fold enhancement to complement medi-
ated lysis (Fig. 3F). These results and the pattern
of B4GALNT2 gene expression strongly indicate
that the porcine B4GALNT2 enzyme produces an
immunogenic non-Gal glycan on endothelial cells
which contributes in part to the non-Gal immune
response after pig-to-baboon cardiac xenotrans-
plantation.
The precise structure of the glycan(s) produced
on pig endothelial cells by the B4GALNT2 enzyme
remains under investigation. Classically in humans
and mice expression of B4GALNT2 produces the
Sd
a antigen. Consistent with this we detect
increased expression of the Sd
a antigen, based on
KM694 antibody and DBA lectin binding, in
HEK-B4T cells but surprisingly do not observe
anti-Sd
a KM694 antibody binding to PAECs. It is
unclear why this is the case. Ongoing glycan proﬁl-
ing of HEK and HEK-B4T cells suggests that the
porcine B4GALNT2 enzyme may produce a wider
variety of GalNAc glycans in HEK-B4T cells then
normally attributed to the human of mouse
enzyme (data not shown). Alternatively KM694
binding may be aﬀected by the presentation of the
Sd
a epitope on pig cells, possibly due to inclusion
of N-glycolylneuraminic acid (Neu5GC) in the
structure. In any case, our absorption experiments
(Fig. 4) show that GTKO PAECs and HEK-B4T
cells share B4GALNT2 dependent antigens which
are not present on HUVECs. Interestingly, an
induced antibody response in baboons to trace
acidic cardiac glycolipids has been reported [8].
Whether this antibody response is related to the
glycan produced by B4GALNT2 remains to be
determined.
There are a limited set of potential antibody
and glycan antigen combinations which may be
involved in xenogeneic antibody dependent
inﬂammatory processes. Antibody to the Gal anti-
gen is the dominant xenoreactivity in both
humans and Old World non-human primates [1].
Anti-Gal antibodies are known to be suﬃcient to
induce organ rejection of Gal-positive vascular
grafts [33–35] and to accelerate calciﬁcation of
Fig. 4. Serum absorption of pig-to-baboon induced antibody
to HEK-B4T (B4T) cells. Sensitized baboon serum was
absorbed by incubating baboon serum (1 : 10 dilution) with
1 9 10
7 GTKO PAECs (A) or HUVECs (B) for 1 h at 4 °C.
Absorption was performed 3 times for each cell type. IgG bind-
ing was analyzed by ﬂow cytometry in dilutions from 1 : 20 to
20 : 48. (A) Closed symbols IgG binding from whole serum to
GTKO PAECs (circle) and HEK-B4T cells (triangle). Open
symbols are IgG binding after absorption with GTKO PAECs.
Over the dilution range, absorption reduced IgG binding by an
average of 89% for GTKO PAECs and 94% for HEK-B4T
cells. (B) Closed symbols IgG binding from whole serum to
GTKO PAECs (circle), HEK-B4T cells (triangle) and HUVEC
(square). Open symbols are IgG binding after absorption with
HUVECs. Absorption reduced HUVEC reactivity on average
by 96%, had a minimal eﬀect on IgG binding to GTKO
PAECs (0.05%) and only a minor reduction of IgG binding to
HEK-B4T (12%) cells.
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but not nonhuman primates, also make a complex
array of antibody to a common mammalian sialic
acid modiﬁcation Neu5GC [37]. This antibody
reactivity is widely expected to contribute to xeno-
graft rejection in humans [38–41] but its signiﬁ-
cance remains uncertain due to the absence of
anti-Neu5GC antibody in experimental non-
human primate models. Screening strategies based
on panels of deﬁned oligosaccharides have failed
to detect xenogeneic sensitization to other
common oligosaccharides (Forssman antigen and
a- and b-lactosamine) [42,43]. The results pre-
sented in this study indicate that porcine B4GAL-
NT2 produces an immunogenic non-Gal glycan
which contributes to the induced non-Gal anti-
body response in the pig-to-baboon xenotrans-
plant model. It remains to be determined if
antibody to this glycan contributes to xenograft
rejection. Additionally, while most humans
express low levels of anti-Sd
a antibody which
agglutinates rare human red blood cells with high
levels of Sd
a antigen (CAD or super Sd
a) [17],
whether an anti-Sd
a immune response will occur in
humans exposed to porcine tissues and the rela-
tionship between human anti-Sd
a antibody and the
immune response in observed baboons remains to
be determined.
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